Latest Health News

Island Pharmaceuticals is accelerating development of its broad-spectrum antiviral Galidesivir, progressing clinical, regulatory, and manufacturing milestones under the FDA Animal Rule pathway with expanded USAMRIID collaboration and biodefence positioning.

Vitasora Health Limited has secured $4 million in a strongly oversubscribed placement, anchored by a $3 million cornerstone investment from private investor Bob Peters. The capital boost supports rapid growth in monthly billings and funds the company through expected cashflow breakeven in the second half of 2026.

Emyria Limited is progressing its national network of psychedelic-assisted therapy clinics, reporting durable patient outcomes, expanding funding sources, and benefiting from regulatory changes that broaden therapist eligibility.

Micro-X has cleared a critical design review for its Full Body CT system, unlocking a $1.6 million milestone payment from US government partner ARPA-H and moving into prototype manufacturing.

ImpediMed has successfully closed an oversubscribed Share Purchase Plan, raising $2.1 million following a $13.2 million institutional placement. The strong shareholder response underscores confidence ahead of a key shareholder vote.

Wesfarmers outlines a bold growth and productivity agenda centred on AI integration, expanding retail footprints, and lithium project progress, underpinning strong shareholder returns and portfolio resilience.

Resonance Health is progressing its MRI Liver Fibrosis device through late-stage clinical validation, targeting FDA biomarker qualification, while maintaining a profitable SaaMD platform and forecasting $16 million revenue for FY26.

LTR Pharma has secured a binding US telehealth commercialisation framework for its intranasal erectile dysfunction treatment ROXUS, committing to at least 150,000 prescriptions in the first year and granting exclusivity to Shed Holdings' platform.

Maritana Minerals has increased the processing capacity of its Black Swan Processing Hub to 2.5 million tonnes per annum, with construction set to begin mid-2026 and first production expected in the second half of 2027.

Mayne Pharma has received $14.4 million from Cosette Pharmaceuticals covering legal costs and interest following a Supreme Court ruling in its favour. The legal battle continues with Cosette’s appeal decision pending.

Nex Metals Explorations has finalised the sale of its 20% stake in the Yundamindra and Kookynie Gold Joint Venture to Arika Resources, securing $0.5 million in net cash and a significant shareholding. The move clears joint venture funding obligations and redirects capital towards advancing its Kookynie Tailings Project and Egyptian exploration.

Findi Limited has transitioned Stephen Benton to Non-Executive Chairman while Nicholas Smedley refocuses on the Indian business and TSI IPO plans. A strategic review aims to sharpen capital allocation and progress the Payments Bank licence.